ChatGPT: Ally or Enemy in the World of Medical Publishing?

Date:

The International Committee of Medical Journal Editors (ICMJE) has released new guidelines for researchers wanting to use artificial intelligence (AI) language models for scientific manuscript writing and revisions. The guidelines state that these tools should not be listed as authors and that researchers must note how AI-assisted technologies were used. While AI tools can help with tasks such as writing, analyzing data, and catching mistakes, they are also prone to errors and can generate text that seems plausible but may not be supported by data. Meanwhile, the use of AI tools in medical publishing is here to stay, with experts suggesting that these tools could help limit linguistic disparities in scientific publishing and alleviate the burden of some monotonous or mechanical tasks. However, stakeholders warn that AI models are a black box and that researchers using these tools must be aware of methodology to prevent any incorrect, incomplete, or biased output. The guidelines recommend that authors of manuscripts using AI technology to write should carefully review and edit the results, provide all the prompts used to generate new text or analytical work, and avoid plagiarism. All authors of a manuscript are solely responsible for the content in articles that used AI-assisted technology.

See also  The Future of Stock Trading: AI's Growing Influence and Ethical Considerations

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.